Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer
Clinical trial NCT00193453 · COMPLETED
Trial details
- NCT number
- NCT00193453
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2009-02-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.